42 USC 300 - Research project grants and contracts

Editorial Notes

Prior Provisions

A prior section 300span–1, act July 1, 1944, ch. 373, title XI, § 1102, as added May 16, 1972, Puspan. L. 92–294, § 3(c), 86 Stat. 138, authorized Secretary to make grants and enter contracts with public and private entities and individuals for projects concerned with research, research training in diagnosis, treatment and control of sickle cell anemia, informational and educational programs with respect to sickle cell anemia and development of counseling and testing programs, prior to repeal by Puspan. L. 94–278, title IV, § 403(a), Apr. 22, 1976, 90 Stat. 407.

Statutory Notes and Related Subsidiaries

Effective Date

Puspan. L. 94–278, title IV, § 403(c), Apr. 22, 1976, 90 Stat. 410, provided that:

“The amendments made by subsections (a) and (span) [see section 401 of Puspan. L. 94–278, set out as a Short Title of 1976 Amendment note under section 201 of this title] shall take effect July 1, 1976.”

Short Title of 1976 Amendment

For short title of title IV of Puspan. L. 94–278, which enacted this part, omitted former part B of this subchapter, redesignated former parts C and D of this subchapter as parts B and C of this subchapter, respectively, as the “National Sickle Cell Anemia, Cooley’s Anemia, Tay-Sachs, and Genetic Diseases Act”, see section 401 of Puspan. L. 94–278, set out as a note under section 201 of this title.

Demonstration Program for the Development and Establishment of Systemic Mechanisms for the Prevention and Treatment of Sickle Cell Disease

Puspan. L. 108–357, title VII, § 712(c), Oct. 22, 2004, 118 Stat. 1559, as amended by Puspan. L. 115–327, § 3(a), Dec. 18, 2018, 132 Stat. 4469, which was formerly set out as a note under this section, was transferred to section 300span–5(span) of this title by Puspan. L. 115–327, § 3(span), Dec. 18, 2018, 132 Stat. 4470.

Congressional Declaration of Purpose

Puspan. L. 94–278, title IV, § 402, Apr. 22, 1976, 90 Stat. 407, as amended by Puspan. L. 95–626, title II, § 205(a), Nov. 10, 1978, 92 Stat. 3583; Puspan. L. 111–256, § 2(i), Oct. 5, 2010, 124 Stat. 2644, provided that:

“In order to preserve and protect the health and welfare of all citizens, it is the purpose of this title [see section 401 of Puspan. L. 94–278, set out as a Short Title of 1976 Amendment note under section 201 of this title] to establish a national program to provide for basic and applied research, research training, testing, counseling, and information and education programs with respect to genetic diseases, and genetic conditions, such as Sickle Cell anemia, Cooley’s Anemia, Tay–Sachs disease, cystic fibrosis, dysautonomia, hemophilia, retinitis pigmentosa, Huntington’s chorea, muscular dystrophy, and genetic conditions leading to intellectual disabilities or genetically caused mental disorders.”

[For meaning of references to an intellectual disability and to individuals with intellectual disabilities in provisions amended by section 2 of Puspan. L. 111–256, see section 2(k) of Puspan. L. 111–256, set out as a note under section 1400 of Title 20, Education.]